FCAMR | Fc receptor, IgA, IgM, high affinity | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
FCRL1 | Fc receptor-like 1 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FCRL5 | Fc receptor-like 5 | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Tissue enhanced |
FUT7 | Fucosyltransferase 7 (alpha (1,3) fucosyltransferase) | | | | | | Tissue enhanced |
GAPT | GRB2-binding adaptor protein, transmembrane | | | | | | Tissue enhanced |
GCSAM | Germinal center-associated, signaling and motility | | | | | | Tissue enhanced |
GNGT2 | Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | RAS pathway related proteins
| | | | | Tissue enhanced |
GP1BA | Glycoprotein Ib (platelet), alpha polypeptide | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR114 | G protein-coupled receptor 114 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR174 | G protein-coupled receptor 174 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR18 | G protein-coupled receptor 18 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GPR82 | G protein-coupled receptor 82 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GRAP | GRB2-related adaptor protein | Plasma proteins
| | | | | Tissue enhanced |
GRAPL | GRB2-related adaptor protein-like | | | | | | Tissue enhanced |
GSG2 | Germ cell associated 2 (haspin) | Enzymes
| | | | | Tissue enhanced |
HLA-DQA2 | Major histocompatibility complex, class II, DQ alpha 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ICOS | Inducible T-cell co-stimulator | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IGLL5 | Immunoglobulin lambda-like polypeptide 5 | | | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Transcription factors
| | | | | Tissue enhanced |
IL17A | Interleukin 17A | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL17F | Interleukin 17F | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
IL17REL | Interleukin 17 receptor E-like | | | | | | Tissue enhanced |
IL21R | Interleukin 21 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
IL22RA2 | Interleukin 22 receptor, alpha 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
IL23A | Interleukin 23, alpha subunit p19 | Predicted secreted proteins
| | | | | Tissue enhanced |
IL26 | Interleukin 26 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IL27RA | Interleukin 27 receptor, alpha | Predicted membrane proteins
| | | | | Tissue enhanced |
IL2RG | Interleukin 2 receptor, gamma | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ITK | IL2-inducible T-cell kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
KBTBD8 | Kelch repeat and BTB (POZ) domain containing 8 | | | | | | Tissue enhanced |
KIAA0125 | KIAA0125 | | | | | | Tissue enhanced |
KLHL6 | Kelch-like family member 6 | | | | | | Tissue enhanced |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KRT24 | Keratin 24 | Plasma proteins
| | | | | Tissue enhanced |
KRT36 | Keratin 36 | Plasma proteins
| | | | | Tissue enhanced |
KRT80 | Keratin 80 | Plasma proteins
| | | | | Tissue enhanced |
LAX1 | Lymphocyte transmembrane adaptor 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
LCK | Lymphocyte-specific protein tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
LEF1 | Lymphoid enhancer-binding factor 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
LHX8 | LIM homeobox 8 | Transcription factors
| | | | | Tissue enhanced |
LIMD2 | LIM domain containing 2 | | | | | | Tissue enhanced |
LRMP | Lymphoid-restricted membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
LRRC15 | Leucine rich repeat containing 15 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LTA | Lymphotoxin alpha | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
LY9 | Lymphocyte antigen 9 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
LYPD2 | LY6/PLAUR domain containing 2 | Predicted secreted proteins
| | | | | Tissue enhanced |